DBV Technologies Announces the Filing of its 2026 Half-Year Report - Conditions for Accessing or Consulting the Report
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
Goldgroup Mining and Gold Resource Corporation Announce Closing of Business Combination and Goldgroup's Anticipated Listing on the NYSE American
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for July 22nd & 23rd
Metalsource Mining Identifies High Priority Drill Targets Across 2.4 Kilometres to Drive the Next Phase of Exploration at Silver Hill
